The ins and outs of universal childhood influenza vaccination

Pieter Fraaij, Rogier Bodewes, Ab Osterhaus, Guus Rimmelzwaan

Research output: Contribution to journalArticleAcademicpeer-review

8 Citations (Scopus)


Influenza viruses continue to cause disease of varying severity among humans. People with underlying disease and the elderly are at increased risk of developing severe disease after infection with an influenza virus. As effective and safe vaccines are available, the WHO has recommended vaccinating these groups against influenza annually. In addition to this recommendation, public health authorities of a number of countries have recently recommended vaccinating all healthy children aged 6-59 months against influenza. Here, we review the currently available data concerning the burden of disease in children, the economical impact of implementing universal vaccination of children, the efficacy of currently available influenza virus vaccines, the theoretical concerns regarding preventing immunity otherwise induced by infections with seasonal influenza viruses, and finally, how to address these concerns.
Original languageUndefined/Unknown
Pages (from-to)1171-1184
Number of pages14
JournalFuture Microbiology
Issue number10
Publication statusPublished - 2011

Research programs

  • EMC MM-04-27-01

Cite this